Recombinant viruses as a tool for therapeutic vaccination against human cancers

This publication has 64 references indexed in Scilit:

• Canarypox Virus-Mediated Interleukin 12 Gene Transfer into Murine Mammary Adenocarcinoma Induces Tumor Suppression and Long-Term Antitumoral Immunity
  Human Gene Therapy, 1998
• Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5
  Science, 1997
• Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types
  Nature Biotechnology, 1996
• Limited Antitumor T Cell Response in Melanoma Patients Vaccinated with Interleukin-2 Gene-Transduced Allogeneic Melanoma Cells
  Human Gene Therapy, 1996
• Comparison of the efficacy of replication-defective adenovirus and Nyvac poxvirus as vaccine vectors in mice
  Vaccine, 1996
• Phase I Study of Recombinant CEA Vaccinia Virus Vaccine with Post Vaccination CEA Peptide Challenge. Medical University of South Carolina, Charleston, South Carolina
  Human Gene Therapy, 1996
• Recombinant Adenoviruses as Vaccines
  Biologicals, 1995
• Protective Vaccination Against Primary And Recurrent Disease Caused By Herpes Simplex Virus (HSV) Type 2 Using A Genetically Disabled HSV-1
  The Journal of Infectious Diseases, 1994
• Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment
  Cell, 1993
• Antitumor Activity and Immune Responses Induced by a Recombinant Carcinoembryonic Antigen-Vaccinia Virus Vaccine
  JNCI Journal of the National Cancer Institute, 1992